APA (7th ed.) Citation

C, E., MJ, D., & LS, B. (2025). A physiologically based pharmacokinetic (PBPK) model describing the kinetics of a commercial mixture α-, β-, and γ-hexabromocyclododecane exposure in mice. Archives of toxicology, 99(3), 1043. https://doi.org/10.1007/s00204-024-03939-4

Chicago Style (17th ed.) Citation

C, Emond, DeVito MJ, and Birnbaum LS. "A Physiologically Based Pharmacokinetic (PBPK) Model Describing the Kinetics of a Commercial Mixture α-, β-, and γ-hexabromocyclododecane Exposure in Mice." Archives of Toxicology 99, no. 3 (2025): 1043. https://doi.org/10.1007/s00204-024-03939-4.

MLA (9th ed.) Citation

C, Emond, et al. "A Physiologically Based Pharmacokinetic (PBPK) Model Describing the Kinetics of a Commercial Mixture α-, β-, and γ-hexabromocyclododecane Exposure in Mice." Archives of Toxicology, vol. 99, no. 3, 2025, p. 1043, https://doi.org/10.1007/s00204-024-03939-4.